November 16, 2016 - Atlanta & Houston - DiabetesAmerica, a provider of healthcare services focused solely on diabetics, and Curant Health, a leading medication management company, announced today the launch of a pilot program intended to improve outcomes for diabetes patients. The short-term goals of the pilot are two-fold and incorporate Curant Health’s Patient Support […]
What do we know? We have long said that medication adherence is the influential lever that can lower healthcare waste, which ranges from $105 to $300 billion annually. However, without medication fill there can be no medication adherence. Studies have shown that the percentage of patients who never get their medications filled are between 28% […]
Despite the presidential outcomes, we in the healthcare industry will still be faced with a heavy issue: how to go about reining in drug costs. Focus on adherence in real-world conditions. Our C the Cure program for a cohort of hepatitis C patients co-infected with HIV resulted in 90% of the patients having a sustained […]
From ACG 2016 - First of its kind study by Johns Hopkins and Curant Health finds MTM increases adherence over 30 percent compared to the standard of care for patients with Inflammatory Bowel Disease. October 17, 2016 ATLANTA & LAS VEGAS--(BUSINESS WIRE)--Curant Health, provider of enhanced medication therapy management and specialty pharmacy services, and Johns […]
October 13, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Adherence in real-world conditions, streamlining prior authorizations and securing stakeholder buy in on the price/value curve can reign in drug spending no matter who becomes president. Here are three ways to help reign in drug costs. 1. Focus on adherence in […]
Study evaluates the Impact of Trough Level-Based Infliximab Dosing on Clinical and Endoscopic Remissions in Patients with IBD October 13, 2016 (Atlanta and Chicago) - Northwestern University Feinberg School of Medicine and Curant Health have announced a new prospective study entitled, “A Collaborative Study to Evaluate the Efficacy of Prospective Post-Induction Infliximab Dosing Based on […]
Every year, biotech industry leaders throughout the southeastern United States convene at Georgia Bio’s flagship conference. Georgia Bio 2016 was no different as hundreds of professionals representing pharmaceutical manufacturers, patient advocacy groups, innovative growth stage companies, service providers and academic institutions met at the Cobb Galleria Center on September 28th. Gatherings like Georgia Bio provide […]
October 10, 2016 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the expansion of an existing 340B clinic partnership on October 1, 2016: Chattanooga C.A.R.E.S. - Chattanooga, Tennessee Based on its successful personalized medication management programs proven to increase adherence by 69%, reduce hospital readmissions by 86% […]
October 10, 2016 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - Where have we been and where are we now? We have long maintained that medication adherence is the longest lever available to reduce $105 billion to $300 billion in wasted health care spending every year, according to the Institute for Healthcare […]
We are honored to join top healthcare thought leaders, visionaries and industry peers to discuss medical costs and quality of care at this year’s Florida Association of ACOs conference in Orlando, Florida October 13-14. The Florida Association of ACOs (FLAACOs) permits accountable care organizations and healthcare leaders to collaborate on lowering overall medical costs while […]
